Rodman & Renshaw Initiates Coverage on Passage Bio (NASDAQ:PASG)
Equities researchers at Rodman & Renshaw began coverage on shares of Passage Bio (NASDAQ:PASG – Get Free Report) in a research note issued on Tuesday, StockNewsAPI reports. The firm set a “buy” rating and a $7.00 price target on the stock. Separately, Canaccord Genuity Group lowered their price target on shares of Passage Bio from […]
More Stories
Invesco S&P SmallCap Quality ETF (BATS:XSHQ) Plans Dividend Increase – $0.15 Per Share
Invesco S&P SmallCap Quality ETF (BATS:XSHQ – Get Free Report) declared a dividend on Friday, September 20th, NASDAQ reports. Investors...
Invesco Russell 1000 Dynamic Multifactor ETF (OMFL) to Issue Dividend of $0.11 on September 27th
Invesco Russell 1000 Dynamic Multifactor ETF (BATS:OMFL – Get Free Report) announced a dividend on Friday, September 20th, NASDAQ reports....
Cambria Global Momentum ETF (BATS:GMOM) Raises Dividend to $0.36 Per Share
Cambria Global Momentum ETF (BATS:GMOM – Get Free Report) declared a dividend on Friday, September 20th, NASDAQ reports. Shareholders of...
Invesco Short Duration Bond ETF (ISDB) to Issue Dividend of $0.11 on September 27th
Invesco Short Duration Bond ETF (BATS:ISDB – Get Free Report) announced a dividend on Friday, September 20th, NASDAQ reports. Investors...
Sudan: UN chief alarmed at full-scale assault on El Fasher
The UN Secretary-General is gravely alarmed by reports of a full-scale assault on El Fasher by the Rapid Support Forces...
Lennar (NYSE:LEN) Issues Quarterly Earnings Results, Beats Estimates By $0.28 EPS
Lennar (NYSE:LEN – Get Free Report) posted its quarterly earnings results on Thursday. The construction company reported $3.90 earnings per...